[go: up one dir, main page]

CL2019003737A1 - Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas - Google Patents

Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas

Info

Publication number
CL2019003737A1
CL2019003737A1 CL2019003737A CL2019003737A CL2019003737A1 CL 2019003737 A1 CL2019003737 A1 CL 2019003737A1 CL 2019003737 A CL2019003737 A CL 2019003737A CL 2019003737 A CL2019003737 A CL 2019003737A CL 2019003737 A1 CL2019003737 A1 CL 2019003737A1
Authority
CL
Chile
Prior art keywords
bees
strains
biostimulant
probiotic
lactobacillus kunkeei
Prior art date
Application number
CL2019003737A
Other languages
English (en)
Inventor
Marisol Vargas Concha Yolanda
Landy Arismendi Solís Nolberto
Gerding González Macarena
Tomás Venegas Arenas Robinson
Original Assignee
Univ Concepcion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Concepcion filed Critical Univ Concepcion
Priority to CL2019003737A priority Critical patent/CL2019003737A1/es
Publication of CL2019003737A1 publication Critical patent/CL2019003737A1/es
Priority to PCT/CL2020/050125 priority patent/WO2021119866A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se presentan cepas de Lactobacillus kunkeei y Bifidobacterium asteroides y su uso para elaborar una formulación probiótica bioestimulante para abejas, estas cepas se encuentran depositadas en la Colección Chilena de Recursos Genéticos Microbianos (CChRGM) y permiten reducir las cargas de dos patógenos importantes de las abejas, Nosema ceranae Fries (Microsporidia) y el virus de las alas deformadas (DWV), lo que significa una reducción del 63% de mortalidad de abejas en la colonia infectadas con ambos patógenos, incrementando hasta en un 160% la poblacional de abejas dentro de la colonia, comparadas con aquellas no tratadas.
CL2019003737A 2019-12-18 2019-12-18 Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas CL2019003737A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2019003737A CL2019003737A1 (es) 2019-12-18 2019-12-18 Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas
PCT/CL2020/050125 WO2021119866A1 (es) 2019-12-18 2020-10-09 Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2019003737A CL2019003737A1 (es) 2019-12-18 2019-12-18 Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas

Publications (1)

Publication Number Publication Date
CL2019003737A1 true CL2019003737A1 (es) 2020-06-19

Family

ID=71143855

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003737A CL2019003737A1 (es) 2019-12-18 2019-12-18 Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas

Country Status (2)

Country Link
CL (1) CL2019003737A1 (es)
WO (1) WO2021119866A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008246387B2 (en) * 2007-05-03 2014-06-12 Tobias Olofsson Novel bacteria isolated from fresh honey or the honey producing tract of honey bees

Also Published As

Publication number Publication date
WO2021119866A1 (es) 2021-06-24

Similar Documents

Publication Publication Date Title
ES2561253T3 (es) Bacterias probióticas que tienen actividad antioxidante y uso de las mismas
BR112021022666A2 (pt) Frações de separação e seus métodos e uso
CO2019000099A2 (es) Composiciones que comprenden cepas bacterianas
Raffetseder et al. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility
CO2017011578A2 (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas
UY37439A (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas
MX385047B (es) Composiciones microbianas para alimentacion directa y sus metodos de uso.
Pavlyuk et al. A study of the chemical composition and biological activity of extracts from wild carrot (Daucus carota L.) seeds waste
CO2017004735A2 (es) Moléculas que tienen utilidad plaguicida e intermediarios, composiciones y procedimientos relacionados con las mismas
Gimeno et al. Effect of diluting Marek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses
MX2016003104A (es) Insectos modificados para reducir la expresion genica especifica en los testiculos para los metodos de control biologico.
UY36279A (es) Moléculas que tienen determinadas utilidades pesticidas, e intermediarios, composiciones y procesos relacionados con ellas
CO2018003464A2 (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas
CO2018002706A2 (es) Moléculas que tienen utilidad plaguicida, e intermediarios, composiciones y procesos, relacionados con ellas
BR112016029835B8 (pt) Moléculas com certas utilidades pesticidas, e composições pesticidas
CL2019003737A1 (es) Uso de cepas de lactobacillus kunkeei y bifidobacterium asteroides como bioestimulante probiótica para abejas
Chomel et al. Experimental infection of dogs with various Bartonella species or subspecies isolated from their natural reservoir
Pan et al. Effect of different selenium sources and levels on porcine circovirus type 2 replication in vitro
Chalabaev et al. Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages
Zakirova et al. Case report of application gene construction with VEGF and BMP2 in restoration of tear in the anterior cruciate ligament of a large breed dog
RU2013159073A (ru) Штамм "алексеевский" вируса оспы свиней для вирусологических, молекулярно-генетических, мониторинговых исследований, изготовления вакцин и диагностических препаратов
Pavlovský et al. NEMAJETKOVÁ ÚJMA NA ZDRAVÍ VE VZTAHU K OSOBNOSTI POŠKOZENÉHO.
Дворак et al. BACTERIAL MICROFLORA OF SUGAR BEET SEEDS
Schön The evaluation of routine immunological tests to estimate the risk of progression into active tuberculosis
Ryzhkova et al. The peculiarities of antagonistic activity of Lactobacillus strains isolated from probiotics and different econiches under cultivation conditions different by gas composition